New WHO Guideline on Testing of Counterfeit Medicines
Recommendation
22-24 October 2019
Vienna, Austria
Register now for ECA's GMP Newsletter
The World Health Organization (WHO) has published a new guideline that describes the procedure for checking supposedly counterfeit or suspect medicines.
The WHO distinguishes three types of "Suspect Medicines":
- "Out of specification" medicines
- Unregistered/unlicensed medicines
- Medicines that have been deliberately falsified.
The present guideline deals mainly with the third category. It contains technical assistance for sampling, laboratory testing of supposedly falsified medicinal products and the corresponding reporting. Examples of this can be found in the appendix of the document for
- Analysis methods for package identification
- An information collection form
- Content of a SOP for testing counterfeit tablets
- Flowcharts for the review procedure (decision tree)
Please visit the WHO website for the new WHO guidance testing of "suspect" falsified medicines.
Related GMP News
26/02/2019
GMP Conferences by Topics
- Quality Assurance
- GMP in Biotechnology
- Microbiology
- Regulatory Affairs
- GMP in Pharmaceutical Development
- Quality Control
- GDP
- Sterile / Aseptic Manufacturing
- Computer Validation
- Validation
- Technical Operations
- GMP for APIs and Excipients
- Medical Devices
- GMP Basic Training Courses
- Packaging
- Data Integrity